Seres Therapeutics (MCRB) Short Interest Ratio & Short Volume $0.82 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Seres Therapeutics Short Interest DataSeres Therapeutics (MCRB) has a short interest of 18.05 million shares. This marks a -3.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 4.41 million shares to cover all short positions.Current Short Interest18,050,000 sharesPrevious Short Interest18,660,000 sharesChange Vs. Previous Month-3.27%Dollar Volume Sold Short$14.72 millionShort Interest Ratio4.7 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares170,200,000 sharesPercentage of Shares Shorted10.61%Today's Trading Volume2,243,971 sharesAverage Trading Volume4,409,859 sharesToday's Volume Vs. Average51% Short Selling Seres Therapeutics? Sign up to receive the latest short interest report for Seres Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMCRB Short Interest Over TimeMCRB Days to Cover Over TimeMCRB Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Seres Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202418,050,000 shares $14.72 million -3.3%N/A4.7 $0.82 9/30/202418,660,000 shares $17.65 million +8.4%N/A4.4 $0.95 9/15/202417,220,000 shares $17.21 million +8.0%N/A4.5 $1.00 8/31/202415,940,000 shares $12.76 million -4.8%N/A4.2 $0.80 8/15/202416,750,000 shares $14.82 million +2.4%N/A4.3 $0.89 7/31/202416,360,000 shares $21.92 million -3.8%N/A3.7 $1.34 Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/202417,000,000 shares $20.23 million -17.8%N/A3.4 $1.19 6/30/202420,690,000 shares $14.98 million -9.5%N/A4.3 $0.72 6/15/202422,850,000 shares $16.18 million +1.1%N/A4.9 $0.71 5/31/202422,600,000 shares $22.60 million -0.6%N/A4.5 $1.00 5/15/202422,740,000 shares $21.78 million +6.0%N/A4.7 $0.96 4/30/202421,460,000 shares $21.26 million +21.7%N/A4.6 $0.99 4/15/202417,630,000 shares $10.89 million -6.2%N/A4.4 $0.62 3/31/202418,800,000 shares $14.55 million +2.2%N/A4 $0.77 3/15/202418,400,000 shares $14.46 million +14.3%N/A3.9 $0.79 2/29/202416,100,000 shares $18.35 million +3.3%N/A3.3 $1.14 2/15/202415,590,000 shares $17.46 million No ChangeN/A3.5 $1.12 1/31/202415,590,000 shares $17.62 million -11.2%N/A3.4 $1.13 1/15/202417,550,000 shares $21.06 million +7.8%N/A3.3 $1.20 12/31/202316,280,000 shares $22.79 million -21.8%N/A3.3 $1.40 12/15/202320,810,000 shares $20.66 million -0.7%N/A5 $0.99 11/30/202320,950,000 shares $21.79 million -10.4%N/A6 $1.04 11/15/202323,370,000 shares $28.04 million +1.2%N/A6.8 $1.20 10/31/202323,100,000 shares $35.34 million +1.1%N/A7.3 $1.53 10/15/202322,850,000 shares $34.28 million +7.9%N/A9.3 $1.50 9/30/202321,170,000 shares $50.38 million +3.8%N/A10 $2.38 9/15/202320,400,000 shares $58.34 million +0.8%N/A9.6 $2.86 8/31/202320,230,000 shares $69.79 million -13.4%N/A8.5 $3.45 8/15/202323,350,000 shares $87.56 million +3.6%N/A9.3 $3.75 7/31/202322,550,000 shares $108.47 million +1.7%N/A8.5 $4.81 7/15/202322,180,000 shares $100.25 million -2.9%N/A6.4 $4.52 6/30/202322,830,000 shares $109.36 million +25.0%N/A6.3 $4.79 6/15/202318,260,000 shares $104.45 million +17.7%N/A5.2 $5.72 5/31/202315,520,000 shares $76.82 million +3.4%N/A5.1 $4.95 5/15/202315,010,000 shares $80.00 million +23.2%N/A5.4 $5.33 4/30/202312,180,000 shares $59.38 million +36.1%N/A4.9 $4.88 4/15/20238,950,000 shares $52.45 million +3.4%N/A6.2 $5.86 3/31/20238,660,000 shares $49.10 million -7.0%N/A8.4 $5.67 3/15/20239,310,000 shares $54.00 million +19.1%N/A10.5 $5.80 2/28/20237,820,000 shares $39.49 million +8.9%N/A9.9 $5.05625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 2/15/20237,180,000 shares $36.83 million +9.6%N/A9.9 $5.13 1/31/20236,550,000 shares $35.83 million -0.3%N/A8.9 $5.47 1/15/20236,570,000 shares $36.00 million -3.5%N/A8.2 $5.48 12/30/20226,810,000 shares $38.14 million +43.7%N/A8.5 $5.60 12/15/20224,740,000 shares $27.68 million +11.3%N/A5.7 $5.84 11/30/20224,260,000 shares $27.69 million -1.6%N/A4.4 $6.50 11/15/20224,330,000 shares $30.92 million -9.2%N/A4.4 $7.14 10/31/20224,770,000 shares $42.26 million -3.4%N/A4.8 $8.86 10/15/20224,940,000 shares $33.94 million +0.2%N/A4.9 $6.87 9/30/20224,930,000 shares $31.65 million +45.9%N/A4.7 $6.42 9/15/20223,380,000 shares $24.23 million -1.2%N/A3 $7.17 8/31/20223,420,000 shares $17.58 million +5.2%N/A3 $5.14 8/15/20223,250,000 shares $18.49 million -12.6%3.8%2.8 $5.69 7/31/20223,720,000 shares $15.29 million +4.8%4.6%3 $4.11 7/15/20223,550,000 shares $12.82 million -5.6%4.4%3.1 $3.61 6/30/20223,760,000 shares $12.90 million -25.0%4.6%3.5 $3.43 6/15/20225,010,000 shares $14.13 million +5.7%7.2%5.1 $2.82 5/31/20224,740,000 shares $14.69 million -5.4%6.8%5.6 $3.10 5/15/20225,010,000 shares $18.99 million +0.4%7.2%6.5 $3.79 4/30/20224,990,000 shares $23.60 million +8.2%7.2%6.7 $4.73 4/15/20224,610,000 shares $28.03 million -0.4%6.6%6.1 $6.08 3/31/20224,630,000 shares $32.97 million -14.9%6.7%5.8 $7.12 3/15/20225,440,000 shares $37.37 million -0.4%7.8%6.2 $6.87 2/28/20225,460,000 shares $43.68 million -0.2%7.8%4.3 $8.00 2/15/20225,470,000 shares $46.17 million -1.1%7.9%3.6 $8.44 1/31/20225,530,000 shares $46.12 million -14.8%8.0%3 $8.34 1/15/20226,490,000 shares $52.18 million +9.8%9.3%3.5 $8.04 12/31/20215,910,000 shares $49.23 million -34.3%8.5%3.2 $8.33 12/15/20218,990,000 shares $78.48 million +7.8%12.9%4.7 $8.73 11/30/20218,340,000 shares $89.74 million -6.2%12.0%4.3 $10.76 11/15/20218,890,000 shares $69.43 million +2.0%12.8%4.8 $7.81 10/29/20218,720,000 shares $53.02 million +7.0%12.6%5.5 $6.08 10/15/20218,150,000 shares $51.43 million -10.4%11.8%4.7 $6.31 9/30/20219,100,000 shares $63.34 million +70.1%13.1%4.4 $6.96 9/15/20215,350,000 shares $33.97 million -15.9%7.7%2.5 $6.35 8/31/20216,360,000 shares $40.77 million -9.0%9.2%3.6 $6.41 8/13/20216,990,000 shares $46.48 million +6.1%10.2%4.7 $6.65 7/30/20216,590,000 shares $46.79 million +6.6%9.6%4.5 $7.10 7/15/20216,180,000 shares $125.27 million -2.1%9.0%5.1 $20.27 6/30/20216,310,000 shares $150.49 million -7.5%9.2%7.8 $23.85 6/15/20216,820,000 shares $136.81 million -1.6%9.9%8.7 $20.06 5/28/20216,930,000 shares $146.29 million -2.5%10.1%8.8 $21.11 5/14/20217,110,000 shares $146.89 million -9.5%10.3%7.7 $20.66 4/30/20217,860,000 shares $166.47 million -1.0%11.4%8.1 $21.18 4/15/20217,940,000 shares $163.96 million +1.2%11.6%8.1 $20.65 3/31/20217,850,000 shares $152.53 million +8.6%11.5%7.4 $19.43 3/15/20217,230,000 shares $154.51 million +10.2%10.6%6.2 $21.37 2/26/20216,560,000 shares $123.26 million +10.1%9.6%5.8 $18.79 2/12/20215,960,000 shares $155.32 million -14.2%8.7%5.5 $26.06 1/29/20216,950,000 shares $166.17 million -5.2%10.2%6.6 $23.91625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 1/15/20217,330,000 shares $195.78 million +3.4%10.8%7.3 $26.71 12/31/20207,090,000 shares $186.11 million +56.2%10.4%7.6 $26.25 12/15/20204,540,000 shares $112.64 million -6.8%6.7%5.3 $24.81 11/30/20204,870,000 shares $141.28 million -3.9%7.3%6.4 $29.01 11/15/20205,070,000 shares $174.71 million +6.5%8.4%6.9 $34.46 10/30/20204,760,000 shares $142.13 million -7.9%8.2%4 $29.86 10/15/20205,170,000 shares $167.66 million +12.6%9.0%1.8 $32.43 9/30/20204,590,000 shares $129.94 million No Change7.9%1.6 $28.31 9/15/20204,590,000 shares $125.40 million -12.4%7.9%1.6 $27.32 8/31/20205,240,000 shares $138.81 million -25.5%9.1%1.8 $26.49 8/14/20207,030,000 shares $191.64 million -21.2%13.2%2.5 $27.26 7/31/20208,920,000 shares $33.36 million +16.3%19.6%3.9 $3.74 7/15/20207,670,000 shares $31.68 million +3.1%17.7%11.8 $4.13 6/30/20207,440,000 shares $34.74 million +6.1%17.1%13.2 $4.67 6/15/20207,010,000 shares $30.70 million +4.0%16.1%16 $4.38 5/29/20206,740,000 shares $37.00 million +8.7%15.7%16.9 $5.49 5/15/20206,200,000 shares $28.52 million +10.9%14.5%16.8 $4.60 4/30/20205,590,000 shares $21.86 million +9.6%13.1%17.4 $3.91 4/15/20205,100,000 shares $18.87 million +6.7%12.2%19.3 $3.70 3/31/20204,780,000 shares $17.35 million -7.9%11.4%18.8 $3.63 3/13/20205,187,600 shares $17.59 million +4.8%12.5%19.3 $3.39 2/28/20204,950,000 shares $16.83 million +2.3%12.0%22.9 $3.40 2/14/20204,840,000 shares $14.62 million +1.9%11.9%22.9 $3.02 1/31/20204,750,000 shares $16.96 million +3.3%11.6%22.7 $3.57 1/15/20204,600,000 shares $16.74 million +15.9%11.2%21.8 $3.64 12/31/20193,970,000 shares $12.43 million +6.7%9.7%19.8 $3.13 MCRB Short Interest - Frequently Asked Questions What is Seres Therapeutics' current short interest? Short interest is the volume of Seres Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 18,050,000 shares of MCRB short. Learn More on Seres Therapeutics' current short interest. What is a good short interest ratio for Seres Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MCRB shares currently have a short interest ratio of 5.0. Learn More on Seres Therapeutics's short interest ratio. Is Seres Therapeutics' short interest increasing or decreasing? Seres Therapeutics saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 18,050,000 shares, a decline of 3.3% from the previous total of 18,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Seres Therapeutics' short interest compare to its competitors? Here is how the short interest of companies compare to Seres Therapeutics: FibroGen, Inc. (4.01%), Nektar Therapeutics (3.40%), PureTech Health plc (0.02%), Xeris Biopharma Holdings, Inc. (7.77%), Altimmune, Inc. (31.28%), Terns Pharmaceuticals, Inc. (6.87%), REGENXBIO Inc. (10.10%), Erasca, Inc. (19.21%), Ginkgo Bioworks Holdings, Inc. (22.23%), Anavex Life Sciences Corp. (21.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Seres Therapeutics stock? Short selling MCRB is an investing strategy that aims to generate trading profit from Seres Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Seres Therapeutics? A short squeeze for Seres Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MCRB, which in turn drives the price of the stock up even further. How often is Seres Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MCRB, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies FibroGen Short Squeeze Nektar Therapeutics Short Squeeze PureTech Health Short Squeeze Xeris Biopharma Short Squeeze Altimmune Short Squeeze Terns Pharmaceuticals Short Squeeze REGENXBIO Short Squeeze Erasca Short Squeeze Ginkgo Bioworks Short Squeeze Anavex Life Sciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MCRB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seres Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
